Harun Kundi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Harun Kundi has a total of 199 co-authors. Here are the top co-authors by number of shared publications:
Mustafa Cetin
Cardiology Department, Numune Education and Research Hospital, Ankara
23 shared publicationsEmrullah Kiziltunc
Department of Cardiology, Ankara Numune Education & Research Hospital, Ankara, Turkey
18 shared publicationsEnder Ornek
TC Saglik Bakanligi Ankara Numune Egitim ve Arastirma Hastanesi - Cardiology, Ankara - Turkey
18 shared publications- Emrullah Kızıltunç
Department of Cardiology, Faculty of Medicine, Gazi University, Ankara, Turkey
14 shared publications - Murat Gök
Trakya University, Turquia
11 shared publications Hulya Cicekcioglu
Department of Biochemistry, Ankara Numune Education and Research Hospital, Ankara, Turkey
9 shared publications
Latest Publications
- Open Access
- 13 June 2026
- Published by Elsevier in Structural Heart
- Vol. 10 (8) , 101072
Patterns and Timing of Sequential Transcatheter Valve Interventions After Index TAVR, M-TEER, and TMVR: A Nationwide Medicare Analysis
- 13 June 2026
- Published by Elsevier in Structural Heart
- Vol. 10 (8) , 101072
Open AccessPatterns and Timing of Sequential Transcatheter Valve Interventions After Index TAVR, M-TEER, and TMVR: A Nationwide Medicare Analysis
- Open Access
- 2 June 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (11) , e048751
Early Postrranscatheter Aortic Valve Replacement Heart Failure Hospitalization and Outcomes in Older Patients
Background: Transcatheter aortic valve replacement (TAVR) improves symptoms and survival in patients with severe aortic stenosis, yet the incidence and prognostic significance of early postprocedural heart failure (HF) hospitalization remain incompletely characterized. Our objective is to determine the incidence, clinical characteristics, prognostic implications, and predictors of early HF hospitalization after TAVR. Methods: Using the Medicare Provider Analysis and Review database, we identified fee‐for‐service beneficiaries ≥65 years who underwent TAVR between January 1, 2017, and November 30, 2021. Early post‐TAVR HF hospitalization was defined as at least 1 HF readmission occurring between 31 and 365 days after the index procedure. Patients were classified according to the presence or absence of HF hospitalization during this period. Cox proportional hazards models were used to evaluate the association with mortality after adjustment for clinical, procedural, and sociodemographic factors. Results: Among 233 309 patients undergoing TAVR, 45 502 (19.5%) experienced HF hospitalization within 1 year. Patients with early HF hospitalization had markedly higher mortality compared with those without HF hospitalization, including 1‐year mortality (43.8% versus 3.6%) and 5‐year mortality (80.6% versus 41.0%) (log‐rank P <0.001). After multivariable adjustment, early HF hospitalization was strongly associated with increased mortality (adjusted hazard ratio [HR], 3.17 [95% CI, 3.11–3.22]). The strongest predictors of early HF hospitalization were advanced cardiac damage stage (adjusted‐subdistribution HR, 1.95 [95% CI, 1.88–2.02]) and high‐risk frailty (adjusted‐subdistribution HR, 1.65 [95% CI, 1.58–1.72]), with graded risk across stages. Conclusions: Nearly 1 in 5 older adults undergoing TAVR experience early HF hospitalization, which is associated with markedly increased short‐ and long‐term mortality.
- 2 June 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (11) , e048751
Open AccessEarly Postrranscatheter Aortic Valve Replacement Heart Failure Hospitalization and Outcomes in Older Patients
Background: Transcatheter aortic valve replacement (TAVR) improves symptoms and survival in patients with severe aortic stenosis, yet the incidence and prognostic significance of early postprocedural heart failure (HF) hospitalization remain incompletely characterized. Our objective is to determine the incidence, clinical characteristics, prognostic implications, and predictors of early HF hospitalization after TAVR. Methods: Using the Medicare Provider Analysis and Review database, we identified fee‐for‐service beneficiaries ≥65 years who underwent TAVR between January 1, 2017, and November 30, 2021. Early post‐TAVR HF hospitalization was defined as at least 1 HF readmission occurring between 31 and 365 days after the index procedure. Patients were classified according to the presence or absence of HF hospitalization during this period. Cox proportional hazards models were used to evaluate the association with mortality after adjustment for clinical, procedural, and sociodemographic factors. Results: Among 233 309 patients undergoing TAVR, 45 502 (19.5%) experienced HF hospitalization within 1 year. Patients with early HF hospitalization had markedly higher mortality compared with those without HF hospitalization, including 1‐year mortality (43.8% versus 3.6%) and 5‐year mortality (80.6% versus 41.0%) (log‐rank P <0.001). After multivariable adjustment, early HF hospitalization was strongly associated with increased mortality (adjusted hazard ratio [HR], 3.17 [95% CI, 3.11–3.22]). The strongest predictors of early HF hospitalization were advanced cardiac damage stage (adjusted‐subdistribution HR, 1.95 [95% CI, 1.88–2.02]) and high‐risk frailty (adjusted‐subdistribution HR, 1.65 [95% CI, 1.58–1.72]), with graded risk across stages. Conclusions: Nearly 1 in 5 older adults undergoing TAVR experience early HF hospitalization, which is associated with markedly increased short‐ and long‐term mortality.
- 17 February 2026
- Published by Academician Publishing
- p. 305-314
Uluslararası Veritabanlarından Veri Kullanımı
Sağlık, klinik ve epidemiyolojik araştırmalarda açık veri kullanımı, son yıllarda artan hesaplama gücü, yapay zeka ve makine öğrenimi uygulamalarıyla birlikte giderek daha merkezi bir rol üstlenmiştir. Ulusal temsiliyet yeteneğine sahip büyük ölçekli açık veri setleri, kronik hastalıkların prevalansının izlenmesi, risk faktörlerinin belirlenmesi, önleyici bakım stratejilerinin değerlendirilmesi ve sağlık eşitsizliklerinin ortaya konması açısından benzersiz fırsatlar sunmaktadır. Bununla birlikte, bu veri kaynaklarının heterojen yapısı, karmaşık örnekleme tasarımları ve gizlilikle ilgili etik ve hukuki kısıtlar, araştırmacılar için önemli metodolojik zorluklar yaratmaktadır.Bu kitap bölümü, sağlık alanında açık veri kullanımının kavramsal çerçevesini sunmakta ve Amerika Birleşik Devletleri’nde en yaygın kullanılan iki ulusal anket olan Ulusal Sağlık ve Beslenme İnceleme Araştırması (NHANES) ile Ulusal Sağlık Görüşme Araştırması’nı (NHIS) ayrıntılı biçimde incelemektedir. Bölümde, bu veri setlerinin kapsamı, veri türleri, güçlü yönleri ve sınırlılıkları karşılaştırmalı olarak ele alınmakta; klinik ve epidemiyolojik araştırmalardaki tipik kullanım alanları örneklerle açıklanmaktadır. Ayrıca karmaşık örnekleme tasarımları, ağırlıklandırma yaklaşımları ve nedensel çıkarım kısıtları gibi temel metodolojik hususlar tartışılmakta; açık veri kullanımının etik, hukuki ve yönetişim boyutları ele alınmaktadır. Son olarak, blokzincir ve güvenli veri platformları gibi yeni teknolojik yaklaşımların, açık veri–gizlilik paradoksunu dengelemedeki potansiyel rolü değerlendirilmektedir. The use of open data in health, clinical, and epidemiological research has become increasingly central with the rapid expansion of computational capacity, artificial intelligence, and machine learning applications. Large-scale, nationally representative open datasets offer unique opportunities to examine chronic disease prevalence, identify risk factors, evaluate preventive care strategies, and characterize health disparities at the population level. At the same time, the heterogeneous structure of these data sources, their complex sampling designs, and ethical and legal constraints related to privacy pose substantial methodological challenges for researchers.This book chapter provides a conceptual overview of open data use in health research and focuses on two of the most widely used national surveys in the United States: the National Health and Nutrition Examination Survey (NHANES) and the National Health Interview Survey (NHIS). The scope, data structure, strengths, and limitations of these datasets are reviewed in a comparative framework, alongside illustrative examples of their application in clinical and epidemiological research. Key methodological considerations—including complex survey design, weighting strategies, and limitations in causal inference—are discussed in detail. In addition, the chapter addresses ethical, legal, and governance issues surrounding open health data and explores the potential role of emerging technologies, such as blockchain and secure data platforms, in balancing data accessibility with individual privacy protection.
- 17 February 2026
- Published by Academician Publishing
- p. 305-314
Uluslararası Veritabanlarından Veri Kullanımı
Sağlık, klinik ve epidemiyolojik araştırmalarda açık veri kullanımı, son yıllarda artan hesaplama gücü, yapay zeka ve makine öğrenimi uygulamalarıyla birlikte giderek daha merkezi bir rol üstlenmiştir. Ulusal temsiliyet yeteneğine sahip büyük ölçekli açık veri setleri, kronik hastalıkların prevalansının izlenmesi, risk faktörlerinin belirlenmesi, önleyici bakım stratejilerinin değerlendirilmesi ve sağlık eşitsizliklerinin ortaya konması açısından benzersiz fırsatlar sunmaktadır. Bununla birlikte, bu veri kaynaklarının heterojen yapısı, karmaşık örnekleme tasarımları ve gizlilikle ilgili etik ve hukuki kısıtlar, araştırmacılar için önemli metodolojik zorluklar yaratmaktadır.Bu kitap bölümü, sağlık alanında açık veri kullanımının kavramsal çerçevesini sunmakta ve Amerika Birleşik Devletleri’nde en yaygın kullanılan iki ulusal anket olan Ulusal Sağlık ve Beslenme İnceleme Araştırması (NHANES) ile Ulusal Sağlık Görüşme Araştırması’nı (NHIS) ayrıntılı biçimde incelemektedir. Bölümde, bu veri setlerinin kapsamı, veri türleri, güçlü yönleri ve sınırlılıkları karşılaştırmalı olarak ele alınmakta; klinik ve epidemiyolojik araştırmalardaki tipik kullanım alanları örneklerle açıklanmaktadır. Ayrıca karmaşık örnekleme tasarımları, ağırlıklandırma yaklaşımları ve nedensel çıkarım kısıtları gibi temel metodolojik hususlar tartışılmakta; açık veri kullanımının etik, hukuki ve yönetişim boyutları ele alınmaktadır. Son olarak, blokzincir ve güvenli veri platformları gibi yeni teknolojik yaklaşımların, açık veri–gizlilik paradoksunu dengelemedeki potansiyel rolü değerlendirilmektedir. The use of open data in health, clinical, and epidemiological research has become increasingly central with the rapid expansion of computational capacity, artificial intelligence, and machine learning applications. Large-scale, nationally representative open datasets offer unique opportunities to examine chronic disease prevalence, identify risk factors, evaluate preventive care strategies, and characterize health disparities at the population level. At the same time, the heterogeneous structure of these data sources, their complex sampling designs, and ethical and legal constraints related to privacy pose substantial methodological challenges for researchers.This book chapter provides a conceptual overview of open data use in health research and focuses on two of the most widely used national surveys in the United States: the National Health and Nutrition Examination Survey (NHANES) and the National Health Interview Survey (NHIS). The scope, data structure, strengths, and limitations of these datasets are reviewed in a comparative framework, alongside illustrative examples of their application in clinical and epidemiological research. Key methodological considerations—including complex survey design, weighting strategies, and limitations in causal inference—are discussed in detail. In addition, the chapter addresses ethical, legal, and governance issues surrounding open health data and explores the potential role of emerging technologies, such as blockchain and secure data platforms, in balancing data accessibility with individual privacy protection.
- Open Access
- 14 June 2025
- Published by Wiley in Hong Kong Journal of Emergency Medicine
- Vol. 32 (3)
iCEBc: A new predictor for hemodialysis need in patients with crush injury—experience from the february 6, 2023, Turkey earthquake
Objective: Early diagnosis and treatment of acute renal failure is critical for reducing mortality and morbidity in patients with crush syndrome (CS), which necessitates hemodialysis (HD) treatment in 75% of CS cases. This study aimed to evaluate whether the index of cardio electrophysiological balance‐corrected (iCEBc) and/or other electrocardiographic parameters could predict the need for HD among patients who had suffered from CS following the February 6, 2023 earthquakes in Kahramanmaraş, Turkey.Methods: This single‐center retrospective case‐control study included 130 patients diagnosed with CS. They were divided into two groups: the HD group (n = 56) and the non‐HD group (n = 74).Results: The study group had a mean age of 40.6 ± 16.1 years and 71 (54.6%) were males. iCEBc values in the HD group were significantly higher than those in the non‐HD group (p < 0.001). Multivariate regression revealed that high iCEBc (p = 0.029, odds ratio: 2.286, and 95% confidence intervals: 1.086–4.811), creatine kinase (p < 0.001, OR: 1.037, and 95% CI: 1.016–1.058), and white blood cell count (p = 0.002, OR: 1.112, and 95% CI: 1.038–1.191) were independent predictors of HD treatment. iCEBc > 4.67 predicted the need for HD with 75.0% sensitivity and 56.8% specificity. A new scoring system, ranging from a minimum of 0 to a maximum of 10 points, has been designed. In patients with a score of ≥5, the need for dialysis was approximately seven times higher (p < 0.001, OR: 6.623, and 95% CI: 3.002–14.612). The area under the curve (AUC) of the new scoring system for predicting dialysis necessity was 0.803 (95% CI: 0.729–0.876 and p < 0.001).Conclusion: iCEBc and new scoring system are a simple, rapid, repeatable, and inexpensive parameter that can effectively predict the need for HD treatment in patients with CS.
- 14 June 2025
- Published by Wiley in Hong Kong Journal of Emergency Medicine
- Vol. 32 (3)
Open AccessiCEBc: A new predictor for hemodialysis need in patients with crush injury—experience from the february 6, 2023, Turkey earthquake
Objective: Early diagnosis and treatment of acute renal failure is critical for reducing mortality and morbidity in patients with crush syndrome (CS), which necessitates hemodialysis (HD) treatment in 75% of CS cases. This study aimed to evaluate whether the index of cardio electrophysiological balance‐corrected (iCEBc) and/or other electrocardiographic parameters could predict the need for HD among patients who had suffered from CS following the February 6, 2023 earthquakes in Kahramanmaraş, Turkey.Methods: This single‐center retrospective case‐control study included 130 patients diagnosed with CS. They were divided into two groups: the HD group (n = 56) and the non‐HD group (n = 74).Results: The study group had a mean age of 40.6 ± 16.1 years and 71 (54.6%) were males. iCEBc values in the HD group were significantly higher than those in the non‐HD group (p < 0.001). Multivariate regression revealed that high iCEBc (p = 0.029, odds ratio: 2.286, and 95% confidence intervals: 1.086–4.811), creatine kinase (p < 0.001, OR: 1.037, and 95% CI: 1.016–1.058), and white blood cell count (p = 0.002, OR: 1.112, and 95% CI: 1.038–1.191) were independent predictors of HD treatment. iCEBc > 4.67 predicted the need for HD with 75.0% sensitivity and 56.8% specificity. A new scoring system, ranging from a minimum of 0 to a maximum of 10 points, has been designed. In patients with a score of ≥5, the need for dialysis was approximately seven times higher (p < 0.001, OR: 6.623, and 95% CI: 3.002–14.612). The area under the curve (AUC) of the new scoring system for predicting dialysis necessity was 0.803 (95% CI: 0.729–0.876 and p < 0.001).Conclusion: iCEBc and new scoring system are a simple, rapid, repeatable, and inexpensive parameter that can effectively predict the need for HD treatment in patients with CS.
- 29 October 2023
- Published by Elsevier in The American Journal of Cardiology
- Vol. 211, 57-63
Socioclinical Phenotyping in Patients With Atherosclerotic Cardiovascular Disease: A Latent Class Analysis
- 29 October 2023
- Published by Elsevier in The American Journal of Cardiology
- Vol. 211, 57-63
Socioclinical Phenotyping in Patients With Atherosclerotic Cardiovascular Disease: A Latent Class Analysis
- Open Access
- 18 July 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (14) , e029588
Association Between Claims‐Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND‐DAPT Study
Background: Frailty is rarely assessed in clinical trials of patients who receive dual antiplatelet therapy (DAPT) after percutaneous coronary intervention. This study investigated whether frailty defined using claims data is associated with outcomes following percutaneous coronary intervention, and if there is a differential association in patients receiving standard versus extended duration DAPT. Methods and Results: Patients ≥65 years of age in the DAPT (Dual Antiplatelet Therapy) Study, a randomized trial comparing 30 versus 12 months of DAPT following percutaneous coronary intervention, had data linked to Medicare claims (n=1326), and a previously validated claims‐based index was used to define frailty. Net adverse clinical events, a composite of all‐cause mortality, myocardial infarction, stroke, and major bleeding, were compared between frail and nonfrail patients. Patients defined as frail using claims data (12.0% of the cohort) had higher incidence of net adverse clinical events (23.1%) compared with nonfrail patients (10.7%; P P =0.61), although analyses were underpowered. Bleeding was highest among frail patients who received extended duration DAPT. Conclusions: Among older patients in the DAPT Study, claims‐defined frailty was associated with higher net adverse clinical events. Effects of extended duration DAPT were not different for frail patients, although comparisons were underpowered. Further investigation of how frailty influences ischemic and bleeding risks with DAPT are warranted. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00977938.
- 18 July 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (14) , e029588
Open AccessAssociation Between Claims‐Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND‐DAPT Study
Background: Frailty is rarely assessed in clinical trials of patients who receive dual antiplatelet therapy (DAPT) after percutaneous coronary intervention. This study investigated whether frailty defined using claims data is associated with outcomes following percutaneous coronary intervention, and if there is a differential association in patients receiving standard versus extended duration DAPT. Methods and Results: Patients ≥65 years of age in the DAPT (Dual Antiplatelet Therapy) Study, a randomized trial comparing 30 versus 12 months of DAPT following percutaneous coronary intervention, had data linked to Medicare claims (n=1326), and a previously validated claims‐based index was used to define frailty. Net adverse clinical events, a composite of all‐cause mortality, myocardial infarction, stroke, and major bleeding, were compared between frail and nonfrail patients. Patients defined as frail using claims data (12.0% of the cohort) had higher incidence of net adverse clinical events (23.1%) compared with nonfrail patients (10.7%; P P =0.61), although analyses were underpowered. Bleeding was highest among frail patients who received extended duration DAPT. Conclusions: Among older patients in the DAPT Study, claims‐defined frailty was associated with higher net adverse clinical events. Effects of extended duration DAPT were not different for frail patients, although comparisons were underpowered. Further investigation of how frailty influences ischemic and bleeding risks with DAPT are warranted. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00977938.
- Open Access
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (6) , 1829-1838
Assessment of s-nitrosothiol and thiol/disulfide levels in acute coronary syndrome patients
Background/aim: The level of nitric oxide (NO) is important to protect the heart from ischemic damage in acute coronary syndrome (ACS) patients. S-nitrosothiol (SNO) is a molecule that represents the main form of NO storage in the vascular structure. In addition, dynamic thiol/disulfide homeostasis (TDH) is known to play an important role in maintaining the oxidant-antioxidant balance. In this study, our aim is to evaluate the oxidative/nitrosative stress status according to SNO level and TDH in patients with ACS. Materials and methods: The study included 124 patients who were admitted to the emergency service and 124 consecutive individuals who applied to the cardiology outpatient clinic with cardiac complaints and underwent coronary angiography (CAG). Blood was drawn from all participants included in the study to determine SNO, nitrite, total thiol, native thiol, and disulfide levels after 12 h of fasting. Results: Serum SNO levels were found to be significantly lower in ACS patients compared to the control group (0.3 ± 0.08 vs. 0.4 ± 0.10 µmol/L, successively, p < 0.001). In addition, while the total thiol, native thiol, and native thiol/total thiol levels were lower in the patient group compared to the control group, nitrite, disulfide/native thiol and disulfide/total thiol levels were higher. As a result of multivariate logistic regression analysis, it was determined that age, gender, smoking, low-density lipoprotein cholesterol, glycosylated haemoglobin, and SNO levels were independent predictors in predicting ACS patients. Conclusion: S-nitrosothiol and thiol levels were found to be significantly lower in ACS patients. In addition, SNO molecule was independently associated with the presence of ACS diagnosis.
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (6) , 1829-1838
Open AccessAssessment of s-nitrosothiol and thiol/disulfide levels in acute coronary syndrome patients
Background/aim: The level of nitric oxide (NO) is important to protect the heart from ischemic damage in acute coronary syndrome (ACS) patients. S-nitrosothiol (SNO) is a molecule that represents the main form of NO storage in the vascular structure. In addition, dynamic thiol/disulfide homeostasis (TDH) is known to play an important role in maintaining the oxidant-antioxidant balance. In this study, our aim is to evaluate the oxidative/nitrosative stress status according to SNO level and TDH in patients with ACS. Materials and methods: The study included 124 patients who were admitted to the emergency service and 124 consecutive individuals who applied to the cardiology outpatient clinic with cardiac complaints and underwent coronary angiography (CAG). Blood was drawn from all participants included in the study to determine SNO, nitrite, total thiol, native thiol, and disulfide levels after 12 h of fasting. Results: Serum SNO levels were found to be significantly lower in ACS patients compared to the control group (0.3 ± 0.08 vs. 0.4 ± 0.10 µmol/L, successively, p < 0.001). In addition, while the total thiol, native thiol, and native thiol/total thiol levels were lower in the patient group compared to the control group, nitrite, disulfide/native thiol and disulfide/total thiol levels were higher. As a result of multivariate logistic regression analysis, it was determined that age, gender, smoking, low-density lipoprotein cholesterol, glycosylated haemoglobin, and SNO levels were independent predictors in predicting ACS patients. Conclusion: S-nitrosothiol and thiol levels were found to be significantly lower in ACS patients. In addition, SNO molecule was independently associated with the presence of ACS diagnosis.
- Open Access
- 29 July 2021
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 10, 100183
Association of entirely claims-based frailty indices with long-term outcomes in patients with acute myocardial infarction, heart failure, or pneumonia: a nationwide cohort study in Turkey
- 29 July 2021
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 10, 100183
Open AccessAssociation of entirely claims-based frailty indices with long-term outcomes in patients with acute myocardial infarction, heart failure, or pneumonia: a nationwide cohort study in Turkey
- 29 January 2021
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 32 (7) , 661-662
Trends in acute myocardial infarction volume and related outcomes during the coronavirus disease 2019 pandemic in Turkey
An abstract is unavailable. This article is available as a PDF only.
- 29 January 2021
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 32 (7) , 661-662
Trends in acute myocardial infarction volume and related outcomes during the coronavirus disease 2019 pandemic in Turkey
An abstract is unavailable. This article is available as a PDF only.
- 15 October 2020
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 14 (14) , 1-10
Whole Blood Viscosity Predicts Nondipping Circadian Pattern in Essential Hypertension
Aim:We aimed to investigate the association between whole blood viscosity (WBV) and nondipping pattern in patients with essential hypertension.Materials & methods:A total of consecutive 530 patients who had been evaluated by ambulatory blood pressure monitoring were included. WBV was estimated by using hematocrit and plasma total protein levels for both WBV in low shear rate (0.5 s(-1)) and WBV in high shear rate (208 s(-1)) according to the de Simone's formula.Results:In the multivariate analysis, low shear rate and high shear rate of WBV were associated independently with nondipping pattern in patients with essential hypertension.Conclusion:As a simple, inexpensive and noninvasive tool, WBV seems to be a significant predictor of nondipping hypertension.
- 15 October 2020
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 14 (14) , 1-10
Whole Blood Viscosity Predicts Nondipping Circadian Pattern in Essential Hypertension
Aim:We aimed to investigate the association between whole blood viscosity (WBV) and nondipping pattern in patients with essential hypertension.Materials & methods:A total of consecutive 530 patients who had been evaluated by ambulatory blood pressure monitoring were included. WBV was estimated by using hematocrit and plasma total protein levels for both WBV in low shear rate (0.5 s(-1)) and WBV in high shear rate (208 s(-1)) according to the de Simone's formula.Results:In the multivariate analysis, low shear rate and high shear rate of WBV were associated independently with nondipping pattern in patients with essential hypertension.Conclusion:As a simple, inexpensive and noninvasive tool, WBV seems to be a significant predictor of nondipping hypertension.